Commission Decision of 21 February 2008 on additional guarantees in intra-Community trade of pigs relating to Aujeszky’s disease and criteria to provide information on this disease (notified under document number C(2008) 669) (Codified version) (Text with EEA relevance) (2008/185/EC)

ANNEX I

Member States or regions thereof free of Aujeszky’s disease and where vaccination is prohibited

ISO code	Member State	Regions
CZ	Czech Republic	All regions
DK	Denmark	All regions
DE	Germany	All regions
FR	France	The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Moselle, Nièvre, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
CY	Cyprus	Whole territory
LU	Luxembourg	All regions
AT	Austria	Whole territory
SK	Slovakia	All regions
FI	Finland	All regions
SE	Sweden	All regions
UK	United Kingdom	All regions in England, Scotland and Wales

ANNEX II

Member States or regions thereof where approved Aujeszky’s disease control programmes are in place

ISO code	Member State	Regions
BE	Belgium	Whole territory.
ES	Spain	The territory of the Autonomous Communities of Galicia, País Vasco, Asturias, Cantabria, Navarra, La Rioja. The territory of the provinces of León, Zamora, Palencia, Burgos, Valladolid and Ávila in the Autonomous Community of Castilla y León. The territory of the province of Las Palmas in the Canary Islands.
FR	France	The departments of Côtes-d’Armor, Finistère, Ille-et-Vilaine, Morbihan and Nord.
IT	Italy	The Province of Bolzano.
NL	Netherlands	Whole territory.

ANNEX III Standards for Aujeszky’s disease serological tests — Protocol for the enzyme linked immunosorbent assay (ELISA) for detecting antibodies to Aujeszky’s disease virus (whole virus), to glycoprotein B (ADV-gB), to glycoprotein D (ADV-gD) or to glycoprotein E (ADV-gE)

1. The institutes listed in paragraph 2(d) shall evaluate Elisa ADV-gE tests and kits against the criteria in paragraph 2(a), (b) and (c). The competent authority in each Member State shall ensure that only Elisa ADV-gE kits that meet these standards shall be registered. The examinations listed in 2(a) and (b) must be carried out prior to approval of the test and the examination in 2(c), at least, must thereafter be carried out on each batch.

2. Standardisation, sensitivity and specificity of the test.

(a)

The sensitivity of the test must be of such a level that the following Community reference sera are scored positive:

• Community reference serum ADV 1 at 1:8 dilution,

• Community reference serum ADV-gE A,

• Community reference serum ADV-gE B,

• Community reference serum ADV-gE C,

• Community reference serum ADV-gE D,

• Community reference serum ADV-gE E,

• Community reference serum ADV-gE F.

(b)

The specificity of the test must be of such a level that the following Community reference sera are scored negative:

• Community reference serum ADV-gE G,

• Community reference serum ADV-gE H,

• Community reference serum ADV-gE J,

• Community reference serum ADV-gE K,

• Community reference serum ADV-gE L,

• Community reference serum ADV-gE M,

• Community reference serum ADV-gE N,

• Community reference serum ADV-gE O,

• Community reference serum ADV-gE P,

• Community reference serum ADV-gE Q.

(c)

For batch control, Community reference serum ADV 1 must be scored positive at 1:8 dilution and one of the Community reference sera from ADV-gE G to ADV-gE Q, as listed in point (b), must be scored negative.

For batch control of ADV-gB and ADV-gD kits, Community reference serum ADV 1 must be scored positive at the dilution of 1:2 and Community reference serum Q referred to in (b) should be scored negative.

(d)

The institutes listed below will, in addition, be responsible for checking the quality of the ELISA method in each Member State, and in particular for producing and standardising national reference sera according to the Community reference sera.

AT	AGES: Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH — Institut für veterinärmedizinische Untersuchungen Mödling (Austrian Agency for Health and Consumer Protection — Institute for veterinary investigations Mödling) Robert Koch-Gasse 17 A-2340 Mödling Tel. [phone] Fax [phone] E-mail: [e-mail]
BE	CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
CY	State Veterinary Laboratory Veterinary Services 1417 Athalassa Nicosia
CZ	—
DE	Friedrich-Loeffler-Institut Bundesforschungsinstitut für Tiergesundheit Standort Wusterhausen Seestraße 55 D-16868 Wusterhausen Tel. + 49 33979 80-0 Fax + 49 33979 80-200
DK	National Veterinary Institute, Technical University of Denmark Lindholm DK-4771 Kalvehave
EE	Veterinaar- ja Toidulaboratoorium Kreutzwaldi 30, 51006 Tartu, Estonia Tel. + 372 7 386 100 Faks: + 372 7 386 102 E-mail: [e-mail]
ES	Laboratorio Central de Sanidad Animal de Algete Carretera de Algete, km 8 Algete 28110 (Madrid) Tel. [phone] Fax [phone] E-mail: [e-mail]
FI	Finnish Food Safety Authority Animal Diseases and Food Safety Research Mustialankatu 3 FI-00790 Helsinki, Finland E-mail: [e-mail] Tel. [phone] (exchange) Fax [phone]
FR	Laboratoire d’études et de recherches avicoles, porcines et piscicoles AFSSA site de Ploufragan/Brest — LERAPP BP 53 22440 Ploufragan
UK	Veterinary Laboratories Agency New Haw, Addlestone, Weybridge Surrey KT15 3NB, UK Tel. [phone] Fax [phone]
GR	Centre of Athens Veterinary Institutes 25 Neapoleos Street, GR-153 10 Agia Paraskevi Attiki Tel. [phone]
HU	Mezőgazdasági Szakigazgatási Hivatal Központ, Állat-egészségügyi Diagnosztikai Igazgatóság Central Agricultural Office, Veterinary Diagnostic Directorate Address: 1149 Budapest, Tábornok u. 2. Mailing Address: 1581 Budapest, 146. Pf. 2. Tel. [phone] Fax [phone] E-mail: [e-mail]
IE	Virology Division Central Veterinary Research Laboratory Department of Agriculture and Food Laboratories Backweston Campus Stacumny Lane Celbridge Co. Kildare
IT	Centro di referenza nazionale per la malattia di Aujeszky — Pseudorabbia c/o Istituto zooprofilattico sperimentale della Lombardia e dell’Emilia Romagna, Via Bianchi, 9; 25124 Brescia
LT	National Veterinary Laboratory (Nacionalinė veterinarijos laboratorija) J. Kairiūkščio 10 LT-08409 Vilnius
LU	CODA — CERVA — VAR Veterinary and Agrochemical Research Centre Groeselenberg 99 B-1180 Brussels
LV	Nacionālais diagnostikas centrs (National Diagnostic Centre) Lejupes iela 3, Rīga, LV-1076 Tel. [phone] Fax [phone] E-mail: [e-mail]
MT	—
NL	Centraal Instituut voor Dierziekte Controle CIDC-Lelystad Hoofdvestiging: Houtribweg 39 Nevenvestiging: Edelhertweg 15 Postbus 2004 8203 AA Lelystad
PL	Laboratory Departement of Swine Diseases Państwowy Instytut Weterynaryjny – Państwowy Instytut Badawczy al. Partyzantów 57, 24-100 Puławy Tel. [phone] Fax [phone] E-mail: [e-mail]
PT	Laboratório Nacional de Investigação Veterinária (LNIV) Estrada de Benfica, 701 P-1549-011 Lisboa
SE	Statens veterinärmedicinska anstalt Department of Virology S-751 89 Uppsala Tel. [phone] Fax [phone]
SI	Univerza v Ljubljani Veterinarska fakulteta Nacionalni veterinarski inštitut Gerbičeva 60, SI-1000 Ljubljana
SK	Štátny veterinárny ústav Pod dráhami 918 960 86 Zvolen Slovenska republika

ANNEX IV Criteria on the information to be provided on the occurrence of Aujeszky’s disease (AD) and on plans for the monitoring and eradication of this disease, to be provided in accordance with Article 8 of Council Directive 64/432/EEC

1. Member State: …

2. Date: …

3. Reporting period: …

4. Number of holdings where AD has been detected by means of clinical, serological or virological investigations: …

5. Information on AD vaccination, serological investigations and categorisation of holdings (please complete the attached table):

a Programme under the supervision of the competent authority.
b Pig holdings where serological tests for AD have been carried out with negative results in accordance with an official AD programme and where vaccination has been applied during the previous 12 months.
c Pig holdings which fulfil the conditions of Article 1(3).
Region	Number of pig holdings	Number of pig holdings under an AD-pogrammea	Number of AD not-infected pig holdings(with vaccination)b	Number of AD free pig holdings(without vaccination)c
Total

6. Further information on serological monitoring in Artificial Insemination Centres, for export purposes, in the framework of other surveillance schemes, etc.: …

…

…

…

ANNEX V

REPEALED DECISION WITH LIST OF ITS SUCCESSIVE AMENDMENTS

Commission Decision 2001/618/EC (OJ L 215, 9.8.2001, p. 48).
Commission Decision 2001/746/EC (OJ L 278, 23.10.2001, p. 41).	Only as regards the reference to Decision 2001/618/EC in Article 1
Commission Decision 2001/905/EC (OJ L 335, 19.12.2001, p. 22).	Only as regards the reference to Decision 2001/618/EC in Article 2
Commission Decision 2002/270/EC (OJ L 93, 10.4.2002, p. 7).	Only Article 3
Commission Decision 2003/130/EC (OJ L 52, 27.2.2003, p. 9).
Commission Decision 2003/575/EC (OJ L 196, 2.8.2003, p. 41).
Commission Decision 2004/320/EC (OJ L 102, 7.4.2004, p. 75).	Only Article 2 and Annex II
Commission Decision 2005/768/EC (OJ L 290, 4.11.2005, p. 27).
Commission Decision 2006/911/EC (OJ L 346, 9.12.2006, p. 41).	Only as regards the reference to Decision 2001/618/EC in Article 1 and point 12 of the Annex
Commission Decision 2007/603/EC (OJ L 236, 8.9.2007, p. 7).
Commission Decision 2007/729/EC (OJ L 294, 13.11.2007, p. 26).	Only as regards the reference to Decision 2001/618/EC in Article 1 and point 10 of the Annex

ANNEX VI

Correlation table

Decision 2001/618/EC	This Decision
Article 1(a) and (b)	Article 1, points 1 and 2
Article 1(c) first to fifth indent	Article 1, point 3(a) to (e)
Article 1(d) first to fourth indent	Article 1, point 4(a) to (d)
Article 2(a) and (b)	Article 2, points 1 and 2
Article 2(c) first to third indent	Article 2, point 3(a) to (c)
Article 3(a)	Article 3, point 1
Article 3(b) first and second indent	Article 3, point 2(a) and (b)
Article 3(c) first to sixth indent	Article 3, point 3(a) to (f)
Article 4(a)	Article 4, point 1
Article 4(b) first and second indent	Article 4, point 2(a) and (b)
Article 4(c) first to fifth indent	Article 4, point 3(a) to (e)
Articles 5 to 8	Articles 5 to 8
Article 9	—
Article 10	—
—	Article 9
Article 11	Article 10
Annexes I to IV	Annexes I to IV
—	Annex V
—	Annex VI